These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 12760172)

  • 21. [Case-control study of moyamoya disease].
    Yamaguchi T; Matsushima Y; Takada Y; Niimi Y; Umezu R; Fukuyama Y; Yamaguchi M; Inaba Y
    No To Shinkei; 1989 May; 41(5):485-91. PubMed ID: 2803821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of cortical microvasculature in adult Moyamoya disease.
    Czabanka M; Peña-Tapia P; Schubert GA; Woitzik J; Horn P; Schmiedek P; Vajkoczy P
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1383-7. PubMed ID: 19491920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moyamoya syndrome associated with systemic lupus erythematosus.
    Jeong HC; Kim YJ; Yoon W; Joo SP; Lee SS; Park YW
    Lupus; 2008 Jul; 17(7):679-82. PubMed ID: 18625642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.
    Fujimura M; Shimizu H; Mugikura S; Tominaga T
    Surg Neurol; 2009 Feb; 71(2):223-7; discussion 227. PubMed ID: 18291489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moyamoya disease: collateralization is everything.
    Vajkoczy P
    Cerebrovasc Dis; 2009; 28(3):258. PubMed ID: 19602877
    [No Abstract]   [Full Text] [Related]  

  • 26. Autosomal dominant moyamoya disease maps to chromosome 17q25.3.
    Mineharu Y; Liu W; Inoue K; Matsuura N; Inoue S; Takenaka K; Ikeda H; Houkin K; Takagi Y; Kikuta K; Nozaki K; Hashimoto N; Koizumi A
    Neurology; 2008 Jun; 70(24 Pt 2):2357-63. PubMed ID: 18463369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.
    Tanaka Y; Nariai T; Nagaoka T; Akimoto H; Ishiwata K; Ishii K; Matsushima Y; Ohno K
    J Cereb Blood Flow Metab; 2006 Feb; 26(2):291-300. PubMed ID: 16049427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Giant arteriovenous malformation associated with unilateral moyamoya disease in a child: case report.
    Chen Z; Zhu G; Feng H; Lin J; Wu N
    Surg Neurol; 2007 Jan; 67(1):89-92; discussion 93. PubMed ID: 17210313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synchronous moyamoya syndrome and ruptured cerebral aneurysm in Alagille syndrome.
    Gaba RC; Shah RP; Muskovitz AA; Guzman G; Michals EA
    J Clin Neurosci; 2008 Dec; 15(12):1395-8. PubMed ID: 18842413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptomeningeal enhancement in petients with moyamoya disease: correlation with perfusion imaging.
    Chung PW; Park KY
    Neurology; 2009 May; 72(21):1872-3. PubMed ID: 19470971
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypothermic cardiopulmonary bypass in a patient with moyamoya disease.
    Al-Naimi KT; Mediratta NK; Pennefather SH
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):206-7. PubMed ID: 18834844
    [No Abstract]   [Full Text] [Related]  

  • 33. Indirect revascularisation for paediatric moyamoya disease: the EDAMS technique.
    Ozgur BM; Aryan HE; Levy ML
    J Clin Neurosci; 2006 Jan; 13(1):105-8. PubMed ID: 16410206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical features of adult unilateral moyamoya disease: does it have the same clinical characteristics as typical moyamoya disease?
    Ogata T; Yasaka M; Inoue T; Yasumori K; Ibayashi S; Iida M; Okada Y
    Cerebrovasc Dis; 2008; 26(3):244-9. PubMed ID: 18648196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary percutaneous transluminal angioplasty for early moyamoya disease.
    Rodriguez GJ; Kirmani JF; Ezzeddine MA; Qureshi AI
    J Neuroimaging; 2007 Jan; 17(1):48-53. PubMed ID: 17238869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibromatosis type 1 association with moyamoya disease.
    Koc F; Yerdelen D; Koc Z
    Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
    Huang AP; Liu HM; Lai DM; Yang CC; Tsai YH; Wang KC; Yang SH; Kuo MF; Tu YK
    Cerebrovasc Dis; 2009; 28(3):247-57. PubMed ID: 19602876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan.
    Mugikura S; Fujimura M; Takahashi S; Takase K
    Radiology; 2017 Jul; 284(1):301-303. PubMed ID: 28628405
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease].
    Nanba R; Kuroda S; Takeda M; Shichinohe H; Nakayama N; Ishikawa T; Houkin K; Iwasaki Y
    No Shinkei Geka; 2003 Dec; 31(12):1291-5. PubMed ID: 14719442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Picture of the month--quiz case. Moyamoya disease.
    Sánchez Fernández I; Peters JM
    Arch Pediatr Adolesc Med; 2009 Feb; 163(2):179-80. PubMed ID: 19188651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.